ࡱ> EF l \pThe Free Software Foundation B=PF0*8X@"1 Helvetica1Courier1 Courier New1 Courier New1 Helvetica$#,##0_);($#,##0)$#,##0_);[Red]($#,##0)$#,##0.00_);($#,##0.00)$#,##0.00_);[Red]($#,##0.00)-**_($* #,##0_);_($* (#,##0);_($* "-"_);_(@_)*)'_(* #,##0_);_(* (#,##0);_(* "-"_);_(@_)5,2_($* #,##0.00_);_($* (#,##0.00);_($* "-"??_);_(@_)2+/_(* #,##0.00_);_(* (#,##0.00);_(* "-"??_);_(@_)2$#,##0.00;[Red]$#,##0.003$#,##0.00;[Red]($#,##0.00)4$#,##0;[Red]($#,##00)50.00%;[Red](0.00%)6 0%;[Red](0%)7#,##0.00;[Red](#,##0.00)8#,##0;[Red](#,##0)                + ) , *   Ј ~~ ؈ ~~#؈ ~~ ؈ ~~7#܈ ~~9#܈ ~~4#܈ ~~8#܈ ~~3#܈ ~~83ffff̙̙3f3fff3f3f33333f33CURRENT REPORT PURSUANT"tCURRENT REPORT PURSUANT (1)&(ITEM 901 FINANCIAL STATEMENTS A&SECOND SIGHT MEDICAL PRODUCTS Iy$Conference Call, Balance Sheet"2Investor Relations ContactsJIncome Statement&PInvestor Relations Contacts (1)&lInvestor Relations Contacts (2)&}sInvestor Relations Contacts (3) l    dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? CURRENT REPORT PURSUANT (1)!ITEM 901 FINANCIAL STATEMENTS A!SECOND SIGHT MEDICAL PRODUCTS IConference Call Balance SheetInvestor Relations ContactsIncome Statement!Investor Relations Contacts (1)!Investor Relations Contacts (2)!Investor Relations Contacts (3)U } $ } } $ } <(} $      )!SECOND SIGHT MEDICAL PRODUCTS INC 8-K 11/07/2018CURRENT REPORT PURSUANT+#SECOND SIGHT MEDICAL PRODUCTS, INC.. &(Exact Name of Registrant as Specified in Its Charter)   California6 .(State or Other Jurisdiction of Incorporation) 333-198073 02-0692322 (Commission File Number))!(IRS Employer Identification No.)$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/0sg[,w'r=PF0*8X> @B     l  W  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? CURRENT REPORT PURSUANT!ITEM 901 FINANCIAL STATEMENTS A!SECOND SIGHT MEDICAL PRODUCTS IConference Call Balance SheetInvestor Relations ContactsIncome Statement!Investor Relations Contacts (1)!Investor Relations Contacts (2)!Investor Relations Contacts (3)U } $      )!SECOND SIGHT MEDICAL PRODUCTS INC 8-K 11/07/2018CURRENT REPORT PURSUANT*"12744 San Fernando Road, Suite 400%  Sylmar, California 913420 ((Address of Principal Executive Offices)  (818) 833-50001 )(Registrant?s Telephone Number, Including Area Code)2*(Former Name or Former Address, if ChangedSince Last Report)$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/4sg[-u_SG=PF0*8X> @Z      l    dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? CURRENT REPORT PURSUANTCURRENT REPORT PURSUANT (1)!SECOND SIGHT MEDICAL PRODUCTS IConference Call Balance SheetInvestor Relations ContactsIncome Statement!Investor Relations Contacts (1)!Investor Relations Contacts (2)!Investor Relations Contacts (3)U } } 0      )!SECOND SIGHT MEDICAL PRODUCTS INC 8-K 11/07/20184,ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS Exhibit No. Description   fffffX@0 (Earnings Release of Second Sight Medical - %Products, Inc. dated November 7, 2018  $____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/&@j^RF}qe==PF0*8X> @ l  #  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? CURRENT REPORT PURSUANTCURRENT REPORT PURSUANT (1)!ITEM 901 FINANCIAL STATEMENTS AConference Call Balance SheetInvestor Relations ContactsIncome Statement!Investor Relations Contacts (1)!Investor Relations Contacts (2)!Investor Relations Contacts (3)U } U} $      )!SECOND SIGHT MEDICAL PRODUCTS INC 8-K 11/07/2018+#SECOND SIGHT MEDICAL PRODUCTS, INC./s/ John T. Blake By: John T. Blake  Chief Financial Officer   $ ____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/$,sg[O&=PF0*8X> @  l  +  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? CURRENT REPORT PURSUANTCURRENT REPORT PURSUANT (1)!ITEM 901 FINANCIAL STATEMENTS A!SECOND SIGHT MEDICAL PRODUCTS I Balance SheetInvestor Relations ContactsIncome Statement!Investor Relations Contacts (1)!Investor Relations Contacts (2)!Investor Relations Contacts (3)U } } } a/      )!SECOND SIGHT MEDICAL PRODUCTS INC 8-K 11/07/2018Conference Call Date#Wednesday, November 7, 2018   Time  4:30 PM EST    Telephone U.S: (800) 933-2547   International:(212) 231-2909"Webcast (live and archive)/'www.secondsight.com under the ?InvestorRelations? section.$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/2{oc,r2~rf>=PF0*8X> @2  l  I2  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? CURRENT REPORT PURSUANTCURRENT REPORT PURSUANT (1)!ITEM 901 FINANCIAL STATEMENTS A!SECOND SIGHT MEDICAL PRODUCTS IConference CallInvestor Relations ContactsIncome Statement!Investor Relations Contacts (1)!Investor Relations Contacts (2)!Investor Relations Contacts (3)U } 1      )!SECOND SIGHT MEDICAL PRODUCTS INC 8-K 11/07/2018 Balance Sheet+#SECOND SIGHT MEDICAL PRODUCTS, INC. AND SUBSIDIARY - %Condensed Consolidated Balance Sheets(  (in thousands) $____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/(^T}qe6s=PF0*8X> @ l  -CI  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? CURRENT REPORT PURSUANTCURRENT REPORT PURSUANT (1)!ITEM 901 FINANCIAL STATEMENTS A!SECOND SIGHT MEDICAL PRODUCTS IConference Call Balance SheetIncome Statement!Investor Relations Contacts (1)!Investor Relations Contacts (2)!Investor Relations Contacts (3)U } 2} $ }  } $ }  } $ -                                 )!SECOND SIGHT MEDICAL PRODUCTS INC 8-K 11/07/2018$Investor Relations Contacts: September 30, December 31,  ~   ~      (unaudited)      ASSETS         Current assets:        ! Cash and cash equivalents ~ M  ~ ~z  Accounts receivable, net~ ~ Inventories, net~ R8~ 2*1)Prepaid expenses and other current assets~ ~ n Total current assets~ ~ #Property and equipment, net~ j~ N!Deposits and other assets~ v~  Total assets~ r~ LIABILITIES AND EQUITYCurrent liabilities:Accounts payable~ *~  Accrued expenses~ ~ %%Accrued compensation expenses~ J.~ ('Accrued clinical trial expenses~ ~ . Contract liablilties~ ~ DlznbV&9@'7@K{y ! " # $ % & ' ( ) * + ,          !!Total current liabilities!!~ !u!!!~ !^g!"""""""""%#Commitments and contingencies########$$$$$$$$$%Stockholders? equity%%~ %<%%%~ %*{%&&&&&&&&&2'*Total liabilities and stockholders? equity'~ 'r''~ ''()$*____________________________1+)Created by Morningstar Document Research.0,(http://documentresearch.morningstar.com/u &8, =PF0*8X> @,,++**''''      l  P  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? CURRENT REPORT PURSUANTCURRENT REPORT PURSUANT (1)!ITEM 901 FINANCIAL STATEMENTS A!SECOND SIGHT MEDICAL PRODUCTS IConference Call Balance SheetInvestor Relations Contacts!Investor Relations Contacts (1)!Investor Relations Contacts (2)!Investor Relations Contacts (3)U } 1      )!SECOND SIGHT MEDICAL PRODUCTS INC 8-K 11/07/2018Income Statement+#SECOND SIGHT MEDICAL PRODUCTS, INC. AND SUBSIDIARY , $Condensed Consolidated Statements of  Operations- %(in thousands, except per share data) (unaudited)$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/,|znb3 sg?=PF0*8X> @ l  %zjk  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? CURRENT REPORT PURSUANTCURRENT REPORT PURSUANT (1)!ITEM 901 FINANCIAL STATEMENTS A!SECOND SIGHT MEDICAL PRODUCTS IConference Call Balance SheetInvestor Relations ContactsIncome Statement!Investor Relations Contacts (2)!Investor Relations Contacts (3)U } 6} $ }  } $ }  }  $ } } $ }  } $ %     )!SECOND SIGHT MEDICAL PRODUCTS INC 8-K 11/07/2018$Investor Relations Contacts:Three Months Ended  Nine Months Ended    September 30,    September 30,   ~   ~   ~   ~                     Net sales ~ #  ~ *  ~ &P  ~ K   Cost of sales  ~    ~    ~ ^3   ~ 2  Gross profit~ :~    ~    ~      Operating expenses:     /'Research and development, net of grants~ )~   ~  >v  ~ W" Clinical and regulatory~ ~    ~  5  ~ Selling and marketing~ /~ %  ~    ~ Fn"General and administrative~ r$~ '  ~  B  ~  Total operating expenses~ Œ~ r  ~  Ʒ  ~ c     Loss from operations~ zz~   ~  e  ~ "     &Interest and other income, net~ b~   ~    ~      Net loss~ z~  ~  f  ~ 6     5-Net loss per common share - basic and dilutedQQ  = ףp=ڿ  ٿ     -%Weighted average shares outstanding -~ n2~ ~w  ~    ~ Z?DlznbVqTs( @$$##""            l  s  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? CURRENT REPORT PURSUANTCURRENT REPORT PURSUANT (1)!ITEM 901 FINANCIAL STATEMENTS A!SECOND SIGHT MEDICAL PRODUCTS IConference Call Balance SheetInvestor Relations ContactsIncome Statement!Investor Relations Contacts (1)!Investor Relations Contacts (3)U } 1      )!SECOND SIGHT MEDICAL PRODUCTS INC 8-K 11/07/2018$Investor Relations Contacts:+#SECOND SIGHT MEDICAL PRODUCTS, INC. AND SUBSIDIARY . &Reconciliation of Non-GAAP Information(  to Most Comparable GAAP Measures- %(in thousands, except per share data) (unaudited)$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/,|znbV' r[OC=PF0*8X> @ l    dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? CURRENT REPORT PURSUANTCURRENT REPORT PURSUANT (1)!ITEM 901 FINANCIAL STATEMENTS A!SECOND SIGHT MEDICAL PRODUCTS IConference Call Balance SheetInvestor Relations ContactsIncome Statement!Investor Relations Contacts (1)!Investor Relations Contacts (2)U } !} $ } U} $ } U}  $ } } $ }  } $      )!SECOND SIGHT MEDICAL PRODUCTS INC 8-K 11/07/2018$Investor Relations Contacts:Three Months Ended  Nine Months Ended    September 30,    September 30,   ~   ~   ~   ~                                     Net loss ~ z  ~   ~ f  ~ 6      "Add back non-cash charges:      Stock-based compensation~  ~ *  ~  J-  ~ "/ Excess inventory reserve~ ~   ~    ~ Non GAAP net loss~ F~  ~    ~ J     Net loss per shareQQ  = ףp=ڿ  ٿ     "Add back non-cash charges:      Stock-based compensation{Gz?{Gz?   ?  Q? Excess inventory reserve~ ~   ~    Q#Non GAAP net loss per share)\()\(   ףp= ׿  Gz׿$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/BXznbVq5J~ K?3 =PF0*8X> @             Root Entry FBook    !"#$%&'()*+,-./0123456789:;<=>?@ABCD